Carroll Financial Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.75M | Buy |
22,905
+306
| +1% | +$24.4K | 0.09% | 129 |
|
|
2021
Q3 | $1.7M | Sell |
22,599
-1,037
| -4% | -$78.9K | 0.09% | 134 |
|
|
2021
Q2 | $1.84M | Sell |
23,636
-2,764
| -10% | -$206K | 0.1% | 123 |
|
|
2021
Q1 | $1.94M | Sell |
26,400
-322
| -1% | -$23.8K | 0.12% | 111 |
|
|
2020
Q4 | $2.08M | Sell |
26,722
-491
| -2% | -$37.6K | 0.14% | 98 |
|
|
2020
Q3 | $2.15M | Sell |
27,213
-149
| -0.5% | -$11.7K | 0.17% | 90 |
|
|
2020
Q2 | $2.02M | Buy |
27,362
+611
| +2% | +$46K | 0.17% | 83 |
|
|
2020
Q1 | $1.96M | Sell |
26,751
-1,739
| -6% | -$137K | 0.19% | 83 |
|
|
2019
Q4 | $2.47M | Sell |
28,490
-2,758
| -9% | -$227K | 0.2% | 76 |
|
|
2019
Q3 | $2.51M | Buy |
31,248
+110
| +0.4% | +$8.82K | 0.22% | 69 |
|
|
2019
Q2 | $2.49M | Buy |
31,138
+4,570
| +17% | +$350K | 0.22% | 67 |
|
|
2019
Q1 | $2.11M | Buy |
26,568
+1,899
| +8% | +$142K | 0.2% | 69 |
|
|
2018
Q4 | $1.77M | Sell |
24,669
-211
| -0.8% | -$14.9K | 0.2% | 74 |
|
|
2018
Q3 | $1.68M | Buy |
24,880
+1,840
| +8% | +$117K | 0.18% | 83 |
|
|
2018
Q2 | $1.33M | Sell |
23,040
-363
| -2% | -$20.5K | 0.14% | 98 |
|
|
2018
Q1 | $1.22M | Sell |
23,403
-2,644
| -10% | -$143K | 0.13% | 97 |
|
|
2017
Q4 | $1.4M | Sell |
26,047
-331
| -1% | -$18.4K | 0.15% | 85 |
|
|
2017
Q3 | $1.63M | Buy |
26,378
+217
| +0.8% | +$13.2K | 0.19% | 75 |
|
|
2017
Q2 | $1.6M | Buy |
26,161
+1,175
| +5% | +$71.5K | 0.19% | 74 |
|
|
2017
Q1 | $1.51M | Buy |
24,986
+894
| +4% | +$54.2K | 0.19% | 71 |
|
|
2016
Q4 | $1.35M | Buy |
24,092
+237
| +1% | +$13.9K | 0.19% | 71 |
|
|
2016
Q3 | $1.42M | Buy |
23,855
+1,869
| +9% | +$109K | 0.21% | 68 |
|
|
2016
Q2 | $1.21M | Buy |
21,986
+7,075
| +47% | +$377K | 0.2% | 73 |
|
|
2016
Q1 | $752K | Buy |
14,911
+1,970
| +15% | +$96.5K | 0.14% | 101 |
|
|
2015
Q4 | $652K | Buy |
12,941
+1,103
| +9% | +$55.6K | 0.14% | 102 |
|
|
2015
Q3 | $571K | Buy |
11,838
+42
| +0.4% | +$2.23K | 0.13% | 106 |
|
|
2015
Q2 | $641K | Buy |
11,796
+2,420
| +26% | +$136K | 0.14% | 102 |
|
|
2015
Q1 | $514K | Buy |
9,376
+2,610
| +39% | +$148K | 0.23% | 76 |
|
|
2014
Q4 | $381K | Sell |
6,766
-1,800
| -21% | -$100K | 0.24% | 72 |
|
|
2014
Q3 | $485K | Buy |
8,566
+1,871
| +28% | +$105K | 0.15% | 95 |
|
|
2014
Q2 | $370K | Buy |
6,695
+11
| +0.2% | +$600 | 0.1% | 119 |
|
|
2014
Q1 | $362K | Buy |
6,684
+405
| +6% | +$21K | 0.12% | 108 |
|
|
2013
Q4 | $299K | Sell |
6,279
-613
| -9% | -$28K | 0.11% | 118 |
|
|
2013
Q3 | $313K | Buy |
6,892
+13
| +0.2% | +$594 | 0.12% | 112 |
|
|
2013
Q2 | $304K | Buy |
+6,879
| New | +$307K | 0.15% | 97 |
|
Other funds holding MRK
Carroll Financial Associates's MRK Position: Q4 2021 in Review
Carroll Financial Associates increased its Merck (MRK) stake by 1.4% in Q4 2021, buying an estimated $24.4K and bringing the position to 22,905 shares worth $1.75M. The position accounts for 0.09% of the portfolio, ranked #129.
Carroll Financial Associates first reported a position in MRK in Q2 2013 and has held it in 35 quarters since. The position peaked at $2.51M in Q3 2019. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.
- Carroll Financial Associates held 22,905 shares of Merck worth $1.75M as of Q4 2021.
- Carroll Financial Associates bought 306 Merck shares in Q4 2021, an estimated $24.4K.
- Merck made up 0.09% of Carroll Financial Associates's portfolio in Q4 2021, its #129 holding.
- Carroll Financial Associates first reported a position in Merck in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Merck position peaked at $2.51M in Q3 2019.
- 2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.